These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Formulary decision-making about cephalosporins with similar therapeutic uses. Mabe DM Am J Health Syst Pharm; 2003 May; 60(10 Suppl 1):S12-5. PubMed ID: 12789882 [TBL] [Abstract][Full Text] [Related]
10. The effect of an antimicrobial formulary change on hospital resistance patterns. Empey KM; Rapp RP; Evans ME Pharmacotherapy; 2002 Jan; 22(1):81-7. PubMed ID: 11794434 [TBL] [Abstract][Full Text] [Related]
11. Determining the formulary status of quinolone antibiotics: one institution's approach. Nightingale CH; Lubowski T; On A; Quintiliani R Hosp Formul; 1992 May; 27(5):509-10, 513-4, 516. PubMed ID: 10128710 [TBL] [Abstract][Full Text] [Related]
12. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee. Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic formulary selection. Crowe HM; Quintiliani R Med Clin North Am; 1995 May; 79(3):463-76. PubMed ID: 7752722 [TBL] [Abstract][Full Text] [Related]
14. Results of an antimicrobial control program at a university hospital. Martin C; Ofotokun I; Rapp R; Empey K; Armitstead J; Pomeroy C; Hoven A; Evans M Am J Health Syst Pharm; 2005 Apr; 62(7):732-8. PubMed ID: 15790801 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a cephalosporin education program--a pharmacy education program. Sohn CA; Wolter HA; McSweeney GW Drug Intell Clin Pharm; 1980 Apr; 14(4):272-7. PubMed ID: 10309192 [TBL] [Abstract][Full Text] [Related]
16. Application of decision analysis to drug selection for formulary addition. Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682 [TBL] [Abstract][Full Text] [Related]
17. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Hayman JN; Sbravati EC Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250 [TBL] [Abstract][Full Text] [Related]
18. Formulary control of antimicrobial usage. What price freedom? Dunagan WC; Medoff G Diagn Microbiol Infect Dis; 1993; 16(3):265-74. PubMed ID: 8477583 [TBL] [Abstract][Full Text] [Related]
19. Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective. Huang X; Beresford E; Lodise T; Friedland HD Am J Health Syst Pharm; 2013 Jun; 70(12):1057-64. PubMed ID: 23719884 [TBL] [Abstract][Full Text] [Related]
20. Cephalosporin-use restrictions in teaching hospitals. McCloskey WW; Johnson PN; Jeffrey LP Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]